Ursula Lehnert

Title: Innovations of Ursula Lehnert

Introduction

Ursula Lehnert is a notable inventor based in Richmond, GB. She has made significant contributions to the field of molecular delivery systems, holding a total of 3 patents. Her work focuses on the selective delivery of molecules into cells, which has important implications for therapeutic and diagnostic applications.

Latest Patents

One of her latest patents involves a polypeptide designed for the selective delivery of molecules into cells or marking of cells in diseased tissue regions. This polypeptide features a predominantly hydrophobic sequence that spans a membrane lipid bilayer as a transmembrane helix. It comprises one or more dissociable groups that allow it to insert across a membrane spontaneously in a pH-dependent manner, placing one terminus inside the cell. The polypeptide is conjugated with various functional moieties that deliver and accumulate them at the cell membrane under low extracellular pH conditions. The functional moiety, which is conjugated with the polypeptide terminus placed inside the cell, is translocated through the cell membrane into the cytosol. This innovative peptide and its variants, or non-peptide analogs, can be utilized to deliver therapeutic, prophylactic, diagnostic, imaging, gene regulation, cell regulation, or immunologic agents to or inside of cells in vitro or in vivo in tissue at low extracellular pH.

Career Highlights

Ursula has worked with prestigious institutions such as Yale University and the Board of Governors for Higher Education, State of Rhode Island and Providence Plantations. Her experience in these organizations has contributed to her expertise in molecular biology and peptide design.

Collaborations

Ursula has collaborated with notable colleagues, including Yana K Reshetnyak and Oleg A Andreev. These partnerships have further enhanced her research and development efforts in the field of molecular delivery systems.

Conclusion

Ursula Lehnert's innovative work in the field of molecular delivery systems showcases her significant contributions to science and technology. Her patents reflect her commitment to advancing therapeutic applications and improving healthcare outcomes.